Form 4: AngioDynamics EVP and CFO Stephen Trowbridge Reports Acquisition of Common Stock

Stephen Trowbridge, EVP and CFO of AngioDynamics, reports acquiring 1,927 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• On February 29, 2024, Stephen A. Trowbridge, the EVP and CFO of AngioDynamics Inc., acquired 1,927 shares of common stock.
• The shares were purchased at a price of $4.67 per share.
• This transaction was conducted under the AngioDynamics, Inc. Employee Stock Purchase Plan.
• Following the reported transaction, Trowbridge beneficially owns 128,901 shares of AngioDynamics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction (stock purchase by an executive) which suggests confidence, but it's not a major event that would drastically alter investor sentiment.

Positives

• The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Executive stock purchases are common and are often viewed as a sign of management's confidence in the company's future performance. These transactions are closely watched by investors for insights into the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholders as it signals confidence from a company executive.

Key Dates